March 24, 2014 •
Feature, Personalized Medicine, Science Focus •
Comments (0) •
You must be logged in to post a comment.
With the #InnovationAgenda on the horizon, now's the time to speak up. https://t.co/jyQgCg5uEL
via @genbio: Opko Health to acquire Toronto-based Transition Therapeutics in $60M deal https://t.co/JQWWBXhihI
Use your experiences, challenges and strengths to shape the #Canadianbiotech industry https://t.co/IWoaWQullF
Our September issue will discuss challenges facing the #lifesciences industry today. Share your experiences now! https://t.co/D3FC5in0OD
Innovation is a Canadian value. By taking our survey, you are helping to foster innovation in the #biotech industry https://t.co/BfXBG60ILs
Is the new Liberal majority government a good thing for the life science & biotech industry?
© 2016 Biotechnology Focus™
Powered by Wordpress. Designed by Themnific™
Lost your password?
Username or E-mail:
Username or Email